BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22164433)

  • 1. [The loss of heterozygosity and microsatellite instability analysis in differential diagnostics of leiomyosarcoma and proliferative leiomyoma of the uterus].
    Shikeeva AA; Kekeeva TV; Zavalishina LÉ; Andreeva IuIu; Frank GA
    Arkh Patol; 2011; 73(4):47-50. PubMed ID: 22164433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent loss of heterozygosity for chromosome 10 in uterine leiomyosarcoma in contrast to leiomyoma.
    Quade BJ; Pinto AP; Howard DR; Peters WA; Crum CP
    Am J Pathol; 1999 Mar; 154(3):945-50. PubMed ID: 10079273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microallelotyping defines novel regions of loss of heterozygosity in uterine leiomyomas.
    Canevari Rde A; Pontes A; Rogatto SR
    Mol Carcinog; 2005 Mar; 42(3):177-82. PubMed ID: 15605361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Benign metastatic leiomyoma of the corpus uteri].
    Andreeva IuIu; Danilova NV; Shikeeva AA; Kekeeva TV; Zavalishina LE; Frank GA
    Arkh Patol; 2012; 74(6):39-43. PubMed ID: 23383444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cytogenetic analysis of uterine leiomyoma and leiomyosarcoma by comparative genomic hybridization.
    Levy B; Mukherjee T; Hirschhorn K
    Cancer Genet Cytogenet; 2000 Aug; 121(1):1-8. PubMed ID: 10958933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome aberrations in uterine smooth muscle tumors: potential diagnostic relevance of cytogenetic instability.
    Fletcher JA; Morton CC; Pavelka K; Lage JM
    Cancer Res; 1990 Jul; 50(13):4092-7. PubMed ID: 2354458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different characteristics of mitochondrial microsatellite instability between uterine leiomyomas and leiomyosarcomas.
    Lee JH; Ryu TY; Cho CH; Kim DK
    Pathol Oncol Res; 2011 Jun; 17(2):201-5. PubMed ID: 20853077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent occurrence of loss of heterozygosity among tumor suppressor genes in uterine leiomyosarcoma.
    Zhai YL; Nikaido T; Orii A; Horiuchi A; Toki T; Fujii S
    Gynecol Oncol; 1999 Dec; 75(3):453-9. PubMed ID: 10600306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of allelic imbalances on chromosome 3p in nasopharyngeal carcinoma in Tunisia: high frequency of microsatellite instability in patients with early-onset of the disease.
    Trimeche M; Braham H; Ziadi S; Amara K; Hachana M; Korbi S
    Oral Oncol; 2008 Aug; 44(8):775-83. PubMed ID: 18206419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent chromosomal aberrations in intravenous leiomyomatosis of the uterus: high-resolution array comparative genomic hybridization study.
    Buza N; Xu F; Wu W; Carr RJ; Li P; Hui P
    Hum Pathol; 2014 Sep; 45(9):1885-92. PubMed ID: 25033729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of loss of heterozygosity in serum microsatellite DNA of patients with gastrointestinal stromal tumors.
    Schurr PG; Oikonomou D; Kaifi JT; Merkert P; Wolter S; Kleinhans H; Reichelt U; Mann O; Gawad KA; Strate T; Yekebas EF; Izbicki JR
    J Clin Gastroenterol; 2009 Jan; 43(1):27-35. PubMed ID: 18469721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Smooth muscle tumors of uncertain malignant potential].
    Andreeva YY; Moskvina LV; Frank GA; Zavalishina LE; Babenko OV; Zhevlova AI; Kekeeva TV; Stilidi IS; Davydov MM; Payanidi YG; Kulik IO; Podberezina YL
    Arkh Patol; 2019; 81(3):5-11. PubMed ID: 31317925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling.
    Quade BJ; Wang TY; Sornberger K; Dal Cin P; Mutter GL; Morton CC
    Genes Chromosomes Cancer; 2004 Jun; 40(2):97-108. PubMed ID: 15101043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups.
    Al-Hendy A; Salama SA
    J Soc Gynecol Investig; 2006 Feb; 13(2):136-44. PubMed ID: 16443508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative immunohistochemical and molecular analysis of uterine and extrauterine leiomyosarcomas.
    Rao UN; Finkelstein SD; Jones MW
    Mod Pathol; 1999 Nov; 12(11):1001-9. PubMed ID: 10574596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rearrangement of band 10q22 in leiomyoma and leiomyosarcoma of the uterus.
    Kiechle-Schwarz M; Berger CS; Surti U; Sandberg AA
    Cancer Genet Cytogenet; 1990 Jul; 47(1):95-100. PubMed ID: 2357691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Markers to Differentiate Uterine Leiomyosarcomas from Leiomyomas.
    Guo J; Zheng J; Tong J
    Int J Med Sci; 2024; 21(7):1227-1240. PubMed ID: 38818470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion at chromosome arms 6q16-22 and 10q22.3-23.1 associated with initiation of prostate cancer.
    Lu T; Hano H
    Prostate Cancer Prostatic Dis; 2008; 11(4):357-61. PubMed ID: 18227855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathology, cytogenetics and molecular biology of uterine leiomyomas and other smooth muscle lesions.
    Quade BJ
    Curr Opin Obstet Gynecol; 1995 Feb; 7(1):35-42. PubMed ID: 7742513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsatellite instability in uterine sarcomas.
    Amant F; Dorfling CM; Dreyer L; Vergote I; Lindeque BG; Van Rensburg EJ
    Int J Gynecol Cancer; 2001; 11(3):218-23. PubMed ID: 11437928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.